Abingdon Health (LSE:ABDX) Other Stockholders Equity : £0.14 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Abingdon Health Other Stockholders Equity?

Abingdon Health's Other Stockholders Equity for the quarter that ended in Dec. 2023 was £0.14 Mil.

Abingdon Health's quarterly Other Stockholders Equity increased from Dec. 2022 (£0.12 Mil) to Jun. 2023 (£0.13 Mil) and increased from Jun. 2023 (£0.13 Mil) to Dec. 2023 (£0.14 Mil).

Abingdon Health's annual Other Stockholders Equity increased from Jun. 2021 (£0.09 Mil) to Jun. 2022 (£0.20 Mil) but then declined from Jun. 2022 (£0.20 Mil) to Jun. 2023 (£0.13 Mil).

Abingdon Health Other Stockholders Equity Historical Data

The historical data trend for Abingdon Health's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abingdon Health Other Stockholders Equity Chart

Abingdon Health Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Stockholders Equity

Get a 7-Day Free Trial

0.03

0.07

0.09

0.20

0.13

Abingdon Health Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Stockholders Equity	Get a 7-Day Free Trial					0.17	0.20	0.12	0.13	0.14

Abingdon Health Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Abingdon Health Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Abingdon Health's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Abingdon Health (LSE:ABDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abingdon Health PLC (LSE:ABDX) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ

Website

https://www.abingdonhealth.com

Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also produces tests covering areas such as self-test HIV, equine infection, human fertility, etc. Business operating segments includes; Contract Development comprises development work for third parties. Contract Manufacturing comprises contract development and manufacturing activities. Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from Contract Development segment. Geographically it operates and earns revenue from the UK, USA and Canada, Europe and the rest of the world.

Abingdon Health (LSE:ABDX) Headlines

No Headlines